It was shown that in this case, HmgB1 inhibits DNA repair after damage resulted from formation of stable DNA–cisplatin–HmgB1 complex, which might affect tumor susceptibility to chemotherapy [123]. This evidence concerns the gene HMGB1 and neoplasm.